v3.26.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Distributions in Excess of Earnings
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2024   478,388          
Balance at beginning of period (in shares) at Dec. 31, 2024     (11,004)        
Balance at beginning of period at Dec. 31, 2024 $ 9,648.7 $ 4.8 $ (1,301.2) $ 15,057.3 $ (5,954.6) $ (4,424.1) $ 6,266.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation related activity (in shares)   794          
Stock-based compensation related activity 67.9 $ 0.0   67.9      
Issuance of common stock - stock purchase plan (in shares)   46          
Issuance of common stock - stock purchase plan 8.1 $ 0.0   8.1      
Foreign currency translation adjustment, net of tax 1,471.4       994.9   476.5
Contributions from noncontrolling interest holders 111.3           111.3
Distributions to noncontrolling interest holders (111.8)           (111.8)
Common stock distributions declared (1,595.8)         (1,595.8)  
Impact of sale of Bangladesh partnership on noncontrolling interests             0.0
Net (loss) income 879.1         855.5 23.6
Balance at end of period (in shares) at Jun. 30, 2025   479,228          
Balance at end of period (in shares) at Jun. 30, 2025     (11,004)        
Balance at end of period at Jun. 30, 2025 10,478.9 $ 4.8 $ (1,301.2) 15,133.3 (4,959.7) (5,164.4) 6,766.1
Balance at beginning of period (in shares) at Mar. 31, 2025   479,131          
Balance at beginning of period (in shares) at Mar. 31, 2025     (11,004)        
Balance at beginning of period at Mar. 31, 2025 9,936.3 $ 4.8 $ (1,301.2) 15,077.7 (5,514.0) (4,732.5) 6,401.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation related activity (in shares)   51          
Stock-based compensation related activity 47.5 $ 0.0   47.5      
Issuance of common stock - stock purchase plan (in shares)   46          
Issuance of common stock - stock purchase plan 8.1 $ 0.0   8.1      
Foreign currency translation adjustment, net of tax 877.8       554.3   323.5
Contributions from noncontrolling interest holders 110.5           110.5
Distributions to noncontrolling interest holders (83.1)           (83.1)
Common stock distributions declared (798.7)         (798.7)  
Net (loss) income 380.5         366.8 13.7
Balance at end of period (in shares) at Jun. 30, 2025   479,228          
Balance at end of period (in shares) at Jun. 30, 2025     (11,004)        
Balance at end of period at Jun. 30, 2025 $ 10,478.9 $ 4.8 $ (1,301.2) 15,133.3 (4,959.7) (5,164.4) 6,766.1
Balance at beginning of period (in shares) at Dec. 31, 2025 466,318 479,358          
Balance at beginning of period (in shares) at Dec. 31, 2025 (13,040)   (13,040)        
Balance at beginning of period at Dec. 31, 2025 $ 10,355.3 $ 4.8 $ (1,665.8) 15,215.3 (4,815.8) (5,086.0) 6,702.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation related activity (in shares)   749          
Stock-based compensation related activity 53.2 $ 0.0   53.2      
Issuance of common stock - stock purchase plan (in shares)   56          
Issuance of common stock - stock purchase plan 8.4 $ 0.0   8.4      
Treasury stock activity (in shares)     (1,164)        
Treasury stock activity (202.9)   $ (202.9)        
Foreign currency translation adjustment, net of tax 48.6       154.8   (106.2)
Contributions from noncontrolling interest holders 4.3           4.3
Distributions to noncontrolling interest holders (93.9)           (93.9)
Common stock distributions declared (1,673.3)         (1,673.3)  
Impact of sale of Bangladesh partnership on noncontrolling interests (13.2)           (13.2)
Net (loss) income $ 1,766.0         1,727.0 39.0
Balance at end of period (in shares) at Jun. 30, 2026 465,959 480,163          
Balance at end of period (in shares) at Jun. 30, 2026 (14,204)   (14,204)        
Balance at end of period at Jun. 30, 2026 $ 10,252.5 $ 4.8 $ (1,868.7) 15,276.9 (4,661.0) (5,032.3) 6,532.8
Balance at beginning of period (in shares) at Mar. 31, 2026   480,083          
Balance at beginning of period (in shares) at Mar. 31, 2026     (14,093)        
Balance at beginning of period at Mar. 31, 2026 10,152.1 $ 4.8 $ (1,849.5) 15,236.0 (4,805.3) (5,063.4) 6,629.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation related activity (in shares)   24          
Stock-based compensation related activity 32.5 $ 0.0   32.5      
Issuance of common stock - stock purchase plan (in shares)   56          
Issuance of common stock - stock purchase plan 8.4 $ 0.0   8.4      
Treasury stock activity (in shares)     (111)        
Treasury stock activity (19.2)   $ (19.2)        
Foreign currency translation adjustment, net of tax 101.5       144.3   (42.8)
Contributions from noncontrolling interest holders 3.5           3.5
Distributions to noncontrolling interest holders (64.2)           (64.2)
Common stock distributions declared (836.4)         (836.4)  
Impact of sale of Bangladesh partnership on noncontrolling interests (13.2)           (13.2)
Net (loss) income $ 887.5         867.5 20.0
Balance at end of period (in shares) at Jun. 30, 2026 465,959 480,163          
Balance at end of period (in shares) at Jun. 30, 2026 (14,204)   (14,204)        
Balance at end of period at Jun. 30, 2026 $ 10,252.5 $ 4.8 $ (1,868.7) $ 15,276.9 $ (4,661.0) $ (5,032.3) $ 6,532.8